Clinical Trial Update: Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

View source ↗

Summary

This clinical trial update notes termination of NCT00722254, a University of Utah study investigating reversible secondary myelofibrosis or clonal myeloprolifer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Utah | Conditions: Primary Myelofibrosis, Primary Pulmonary Hypertension | Status: TERMINATED